Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mark Mulligan and Marie Samanovic.
Mark Mulligan
Connection Strength
0.293
Marie Samanovic
  1. B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies. mBio. 2021 08 31; 12(4):e0138621.
    View in: PubMed
    Score: 0.060
  2. Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes. mBio. 2021 06 29; 12(3):e0069621.
    View in: PubMed
    Score: 0.059
  3. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci Transl Med. 2021 05 12; 13(593).
    View in: PubMed
    Score: 0.059
  4. Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities. Sci Rep. 2021 03 10; 11(1):5538.
    View in: PubMed
    Score: 0.058
  5. Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region. Genome Res. 2020 12; 30(12):1781-1788.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.